BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17118648)

  • 1. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
    Ringberg A; Nordgren H; Thorstensson S; Idvall I; Garmo H; Granstrand B; Arnesson LG; Sandelin K; Wallgren A; Anderson H; Emdin S; Holmberg L
    Eur J Cancer; 2007 Jan; 43(2):291-8. PubMed ID: 17118648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening.
    Emdin SO; Granstrand B; Ringberg A; Sandelin K; Arnesson LG; Nordgren H; Anderson H; Garmo H; Holmberg L; Wallgren A;
    Acta Oncol; 2006; 45(5):536-43. PubMed ID: 16864166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
    MacAusland SG; Hepel JT; Chong FK; Galper SL; Gass JS; Ruthazer R; Wazer DE
    Cancer; 2007 Dec; 110(12):2648-53. PubMed ID: 17960606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.
    Holmberg L; Garmo H; Granstrand B; Ringberg A; Arnesson LG; Sandelin K; Karlsson P; Anderson H; Emdin S
    J Clin Oncol; 2008 Mar; 26(8):1247-52. PubMed ID: 18250350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
    Wärnberg F; Bergh J; Zack M; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.
    Jobsen JJ; van der Palen J; Ong F
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):115-22. PubMed ID: 18234450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ of the breast. Increasing importance of radiotherapy as a part of the therapy approach.
    Fietkau R
    Strahlenther Onkol; 2004 Nov; 180(11):682-9. PubMed ID: 15549185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer.
    Martin S; Mannino M; Rostom A; Tait D; Donovan E; Eagle S; Haviland J; Yarnold J
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):502-5. PubMed ID: 18556186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions.
    Keisch M; Vicini F; Beitsch P; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H
    Am J Surg; 2009 Oct; 198(4):505-7. PubMed ID: 19800456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
    Dunne C; Burke JP; Morrow M; Kell MR
    J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
    Wärnberg F; Garmo H; Emdin S; Hedberg V; Adwall L; Sandelin K; Ringberg A; Karlsson P; Arnesson LG; Anderson H; Jirström K; Holmberg L
    J Clin Oncol; 2014 Nov; 32(32):3613-8. PubMed ID: 25311220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
    Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.